| |
|
|
|
| |
|
|
  | | |
autosomal dominant pseudohypoaldosteronism type 1
|
NR3C2*
|
Nr3c2*
|
1 model
|
Alliance of Genome Resources
|
|
Bartter disease type 1
|
SLC12A1*
|
Slc12a1*
|
2 models
|
Alliance of Genome Resources
|
|
Bartter disease type 2
|
KCNJ1*
|
Kcnj1*
|
1 model
|
Alliance of Genome Resources
|
|
Bartter disease type 3
|
CLCNKB*,
CLCNKA
|
Clcnkb*,
Clcnka
|
1 model
|
Alliance of Genome Resources
|
|
Bartter disease type 4a
|
BSND*
|
Bsnd*
|
2 models
|
Alliance of Genome Resources
|
|
Dent disease
|
CLCN5*
|
Clcn5*
|
2 models
|
Alliance of Genome Resources
|
|
Gitelman syndrome
|
SLC12A3*
|
Slc12a3*
|
2 models
|
Alliance of Genome Resources
|
|
Liddle syndrome
|
SCNN1B*
|
Scnn1b*
|
1 model
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
KLHL3*
|
Klhl3*
|
4 models
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
WNK4*
|
Wnk4*
|
1 model
|
Alliance of Genome Resources
|
|
renal tubular acidosis
|
SLC4A4*
|
Slc4a4*
|
1 model
|
Alliance of Genome Resources
|
|
renal tubular acidosis
|
SLC4A1*
|
Slc4a1*
|
1 model
|
Alliance of Genome Resources
|
|
renal tubular acidosis
|
ATP6V0A4*
|
Atp6v0a4*
|
1 model
|
Alliance of Genome Resources
|
| | | |
autosomal recessive pseudohypoaldosteronism type 1
|
SCNN1B
|
Scnn1b*
|
1 model
|
Alliance of Genome Resources
|
|
autosomal recessive pseudohypoaldosteronism type 1
|
SCNN1G
|
Scnn1g*
|
1 model
|
Alliance of Genome Resources
|
|
Bartter disease
|
CLCNKA,
CLCNKB
|
Clcnkb*,
Clcnka
|
1 model
|
Alliance of Genome Resources
|
|
Fanconi syndrome
|
HNF4A
|
Hnf4a*
|
1 model
|
Alliance of Genome Resources
|
|
Fanconi syndrome
|
LRP2
|
Lrp2*
|
1 model
|
Alliance of Genome Resources
|
|
Gitelman syndrome
|
STK39
|
Stk39*
|
3 models
|
Alliance of Genome Resources
|
|
Gitelman syndrome
|
WNK4
|
Wnk4*
|
1 model
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
STK39
|
Stk39*
|
1 model
|
Alliance of Genome Resources
|
|
renal glycosuria
|
HNRNPF
|
Hnrnpf*
|
1 model
|
Alliance of Genome Resources
|
| | | |
Bartter disease
|
BSND*
|
Bsnd
|
|
Alliance of Genome Resources
|
|
Bartter disease
|
SLC12A1*
|
Slc12a1
|
|
Alliance of Genome Resources
|
|
Bartter disease type 4b
|
CLCNKA*,
CLCNKB*
|
Clcnka,
Clcnkb
|
|
Alliance of Genome Resources
|
|
Bartter disease type 5
|
MAGED2*
|
Maged2
|
|
Alliance of Genome Resources
|
|
Dent disease
|
OCRL*
|
Ocrl
|
2 models
|
Alliance of Genome Resources
|
|
Fanconi renotubular syndrome 1
|
GATM*
|
Gatm
|
|
Alliance of Genome Resources
|
|
Fanconi renotubular syndrome 2
|
SLC34A1*
|
Slc34a1
|
|
Alliance of Genome Resources
|
|
Fanconi renotubular syndrome 3
|
EHHADH*
|
Ehhadh
|
|
Alliance of Genome Resources
|
|
Fanconi renotubular syndrome 4
|
HNF4A*
|
Hnf4a
|
|
Alliance of Genome Resources
|
|
Fanconi renotubular syndrome 5
|
NDUFAF6*
|
Ndufaf6
|
|
Alliance of Genome Resources
|
|
Fanconi syndrome
|
SLC2A2*
|
Slc2a2
|
|
Alliance of Genome Resources
|
|
Fanconi syndrome
|
SLC34A1*
|
Slc34a1
|
|
Alliance of Genome Resources
|
|
Gitelman syndrome
|
CLCNKB*,
CLCNKA
|
Clcnka,
Clcnkb
|
|
Alliance of Genome Resources
|
|
iminoglycinuria
|
SLC36A2*
|
Slc36a2
|
|
Alliance of Genome Resources
|
|
Liddle syndrome
|
SCNN1G*
|
Scnn1g
|
|
Alliance of Genome Resources
|
|
Liddle syndrome
|
SCNN1A*
|
Scnn1a
|
|
Alliance of Genome Resources
|
|
low molecular weight proteinuria with hypercalciuric nephrocalcinosis
|
CLCN5*
|
Clcn5
|
|
Alliance of Genome Resources
|
|
nephrogenic syndrome of inappropriate antidiuresis
|
AVPR2*
|
Avpr2
|
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
CUL3*
|
Cul3
|
2 "NOT" models
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
NR3C2*
|
Nr3c2
|
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
SCNN1A*
|
Scnn1a
|
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
SCNN1B*
|
Scnn1b
|
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
SCNN1G*
|
Scnn1g
|
|
Alliance of Genome Resources
|
|
pseudohypoaldosteronism
|
WNK1*
|
Wnk1
|
|
Alliance of Genome Resources
|
|
renal glycosuria
|
SLC5A2*
|
Slc5a2
|
|
Alliance of Genome Resources
|
|
renal tubular acidosis
|
ATP6V1B1*
|
Atp6v1b1
|
|
Alliance of Genome Resources
|
|
renal tubular transport disease
|
CLDN16*
|
Cldn16
|
|
Alliance of Genome Resources
|
|
renal tubular transport disease
|
AUH*
|
Auh
|
|
Alliance of Genome Resources
|
|
X-linked nephrolithiasis type I
|
CLCN5*
|
Clcn5
|
|
Alliance of Genome Resources
|
Excel File